📚 Wiki Antimicrobial & Immune Alamethicin

Alamethicin

● Research tool / Preclinical
Alamethicin
Also known as: Alm, Alamethicin F-50, Voltage-gated peptide channel
Page last reviewed

Quick Summary

Alamethicin is a 20-residue peptaibol (peptide with a high proportion of alpha-aminoisobutyric acid, Aib) from the fungus Trichoderma viride. It is the prototypical voltage-gated peptide ion channel, forming multi-state conductance channels in lipid bilayers whose opening probability is highly dependent on membrane voltage.

Antimicrobial Peptide Preclinical (research tool)
Alamethicin is a 20-residue peptaibol (peptide with a high proportion of alpha-aminoisobutyric acid, Aib) from the fungus Trichoderma viride. It is the prototypical voltage-gated peptide ion channel, forming multi-state conductance channels in lipid bilayers whose opening probability is highly dependent on membrane voltage. Alamethicin has been invaluable as a model system for studying ion channel biophysics and as a tool for membrane research. It has antifungal and antibacterial activity but significant mammalian toxicity limits therapeutic development.
Storage Stability
Lyophilized
1–2 years (-20°C)
Reconstituted
~30 days (2–8°C)
Room temp
Avoid

Mechanism of Action

Voltage-Gated Multi-State Ion Channels

Alamethicin monomers align parallel to the membrane surface at low concentrations (surface state) and insert perpendicularly at higher concentrations or membrane potentials. Barrel-stave pores form from 4-12 alamethicin monomers, with conductance increasing in discrete steps corresponding to the addition of individual peptide molecules to the pore. The voltage-gating arises from dipole moments of the helix (from Aib-dominated structure and C-terminal glutamine residues) that respond to transmembrane voltage. This voltage-dependent, multi-state channel behavior is the unique biophysical feature that makes alamethicin the reference model for voltage-gated ion channels.

Aib Content and Helix Stability

Aib (alpha-aminoisobutyric acid) restricts backbone conformation to alpha-helical geometry more strictly than standard amino acids, resulting in a rigid, well-defined 310-helix. This rigidity is essential for the parallel stacking of alamethicin molecules in the barrel-stave pore. The high Aib content also provides protease resistance, as standard proteases cannot efficiently cleave Aib-containing peptides, contributing to in vivo stability in the membrane environment.


Research Summary

Ion Channel Biophysics Model

Research Tool

Alamethicin-induced channels in black lipid membranes have been studied for over 50 years as a model for voltage-gated channels. The precise control of channel conductance by voltage, temperature, and lipid composition has provided fundamental insights into channel biophysics applicable to voltage-gated Na+, K+, and Ca2+ channels. Single-channel conductance studies with alamethicin established many principles of ion selectivity, channel gating kinetics, and lipid-channel coupling now applied to clinical channelopathies.

Synergistic Activity with Other AMPs

Preclinical

Alamethicin shows synergistic antimicrobial activity with other membrane-active peptides and some conventional antibiotics. Sub-lethal alamethicin concentrations permeabilize membranes, enhancing intracellular antibiotic penetration. In plant pathogen models, alamethicin from Trichoderma is part of the natural biocontrol mechanism against phytopathogens. Engineered peptaibol analogs with modified selectivity profiles are being explored as agricultural biocontrol agents.


Calculate your Alamethicin dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →

Research Protocols

GoalDoseFrequencyRoute
Ion channel research (BLM)Nanomolar to micromolar (lipid bilayer)ContinuousLipid bilayer reconstitution
Membrane permeabilization1-10 ug/mLSingle treatmentDirect (in vitro)

Primary use is as a research tool. No therapeutic applications.


Interactions

Both model ion channels
Different structures and gating mechanisms; both used in lipid bilayer research
Synergy with alpha-helical AMPs
Alamethicin enhances membrane disruption by other AMPs through membrane conditioning

Safety Profile

Hemolytic and cytotoxic to mammalian cells at antimicrobial concentrations, precluding therapeutic use. The non-selective cation channel formation disrupts transmembrane potential of all membrane-containing cells. In vivo toxicity in animal models is significant. Application is as a research tool and model compound, not a therapeutic agent.


References

  • [1]Mueller P and Rudin DO. (1968). Action potentials induced in biomolecular lipid membranes. Nature, 217(5130), 713-719.
  • [2]Sansom MS. (1993). Structure and function of channel-forming peptaibols. Q Rev Biophys, 26(4), 365-421.
Ready to dose Alamethicin?
Get the exact syringe draw
You have read the research. Now run the math. Pick your vial size and BAC water volume, get IU draw in seconds.
Open the Calculator →
Verified Scientific Data Last audited:
Data Sources & External References
Source: peer-reviewed literature  ·  Domain: ascendpeptide.org

Suggest a Change

Alamethicin · wiki page